Veracyte, Inc. (VCYT) has 20 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist Stapley Marc mit 449,653 Aktien. Weitere bedeutende Anteilseigner sind Chambers Rebecca und Febbo Phillip G..
In den letzten 12 Monaten haben Insider 73 Transaktionen in VCYT Aktien getätigt — 15 Käufe (im Wert von RSU Award) und 26 Verkäufe (im Wert von $5.4M). Insider-Verkäufe haben die Käufe in diesem Zeitraum übertroffen.
VCYT Insider-Beteiligungen
Größter Aktionär
Stapley Marc
449,653 Aktien
Käufe (12 Monate)
15
$0.00 Wert
Verkäufe (12 Monate)
26
$5.4M Wert
12-Monats-Transaktionsaktivität
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Stapley Marc |
Chief Executive Officer |
449,653 |
2026-03-10 |
|
| 2 |
Chambers Rebecca |
Chief Financial Officer |
167,377 |
2026-03-10 |
|
| 3 |
Febbo Phillip G. |
Chief Scientific & Med Officer |
146,949 |
2026-03-10 |
|
| 4 |
Leite John |
Chief Commercial Officer-clia |
143,761 |
2026-03-10 |
|
| 5 |
Mcguire Annie |
SVP, General Counsel |
127,598 |
2026-03-10 |
|
| 6 |
Kennedy Keith |
COO / CFO |
116,858 |
2021-03-04 |
|
| 7 |
Nova Tina Susan |
President, Clia U.s. |
76,988 |
2022-03-07 |
|
| 8 |
Epstein Robert S |
Director |
73,919 |
2025-06-23 |
|
| 9 |
Hanna John Walter Jr |
Chief Commercial Officer |
73,844 |
2020-12-04 |
|
| 10 |
Ho Mark |
Officer |
71,728 |
2021-03-04 |
|
| 11 |
Kennedy Giulia C |
Chief Scientific & Med Officer |
65,970 |
2022-12-08 |
|
| 12 |
Barr Eliav |
Director |
51,189 |
2025-06-23 |
|
| 13 |
Wygant Jonathan |
VP, Chief Accounting Officer |
45,434 |
2026-03-10 |
|
| 14 |
Anderson Bonnie H |
Director |
41,377 |
2023-06-06 |
|
| 15 |
Bhanji Muna |
Director |
39,310 |
2025-06-23 |
|
| 16 |
Jones Evan/ Fa |
Director |
29,362 |
2025-11-26 |
|
| 17 |
Hall Christopher M |
President and COO |
28,258 |
2019-06-05 |
|
| 18 |
Holstein Jens |
Director |
27,199 |
2025-11-21 |
|
| 19 |
Miller Thomas F. |
Director |
25,828 |
2025-06-23 |
|
| 20 |
Shafer David Brent |
Director |
25,828 |
2025-06-23 |
|
Aktuelle Transaktionen (letzte 12 Monate)
| Datum |
Name |
Funktion |
Typ |
Aktien |
Kurs |
Wert |
| 2026-03-24 |
Haas Kevin Richard |
Officer |
Unbekannt |
- |
- |
- |
| 2026-03-06 |
Leite John |
Chief Commercial Officer-clia |
RSU-Zuteilung |
36,181 |
- |
- |
| 2026-03-06 |
Mcguire Annie |
SVP, General Counsel |
RSU-Zuteilung |
32,892 |
- |
- |
| 2026-03-06 |
Chambers Rebecca |
Chief Financial Officer |
RSU-Zuteilung |
36,181 |
- |
- |
| 2026-03-06 |
Febbo Phillip G. |
Chief Scientific & Med Officer |
RSU-Zuteilung |
29,603 |
- |
- |
| 2026-03-06 |
Wygant Jonathan |
VP, Chief Accounting Officer |
RSU-Zuteilung |
10,525 |
- |
- |
| 2026-03-06 |
Stapley Marc |
Chief Executive Officer |
RSU-Zuteilung |
92,099 |
- |
- |
| 2026-03-04 |
Leite John |
Chief Commercial Officer-clia |
Informierter Verkauf |
5,260 |
$35.19 |
$185.08K |
| 2026-03-04 |
Mcguire Annie |
SVP, General Counsel |
Informierter Verkauf |
1,664 |
$36.34 |
$60.47K |
| 2026-03-04 |
Chambers Rebecca |
Chief Financial Officer |
Informierter Verkauf |
13,941 |
$36.33 |
$506.46K |
| 2026-03-04 |
Stapley Marc |
Chief Executive Officer |
Informierter Verkauf |
26,279 |
$36.28 |
$953.37K |
| 2026-03-02 |
Leite John |
Chief Commercial Officer-clia |
RSU-Steuereinbehalt |
7,517 |
$36.01 |
$270.69K |
| 2026-03-02 |
Mcguire Annie |
SVP, General Counsel |
RSU-Steuereinbehalt |
6,902 |
$36.01 |
$248.54K |
| 2026-03-02 |
Chambers Rebecca |
Chief Financial Officer |
RSU-Steuereinbehalt |
7,234 |
$36.01 |
$260.5K |
| 2026-03-02 |
Febbo Phillip G. |
Chief Scientific & Med Officer |
Informierter Verkauf |
13,425 |
$36.16 |
$485.43K |
| 2026-03-02 |
Wygant Jonathan |
VP, Chief Accounting Officer |
RSU-Steuereinbehalt |
3,006 |
$36.01 |
$108.25K |
| 2026-03-02 |
Stapley Marc |
Chief Executive Officer |
RSU-Steuereinbehalt |
19,455 |
$36.01 |
$700.57K |
| 2026-02-26 |
Leite John |
Chief Commercial Officer-clia |
RSU-Steuereinbehalt |
8,905 |
$38.75 |
$345.07K |
| 2026-02-26 |
Mcguire Annie |
SVP, General Counsel |
RSU-Steuereinbehalt |
10,867 |
$38.75 |
$421.1K |
| 2026-02-26 |
Chambers Rebecca |
Chief Financial Officer |
RSU-Steuereinbehalt |
12,049 |
$38.75 |
$466.9K |
| 2026-02-26 |
Febbo Phillip G. |
Chief Scientific & Med Officer |
RSU-Steuereinbehalt |
24,486 |
$38.75 |
$948.83K |
| 2026-02-26 |
Stapley Marc |
Chief Executive Officer |
RSU-Steuereinbehalt |
35,841 |
$38.75 |
$1.39M |
| 2025-12-16 |
Mcguire Annie |
SVP, General Counsel |
Informierter Verkauf |
100 |
$43.68 |
$4.37K |
| 2025-12-05 |
Eastham Karin |
Director |
Optionsausübung (Verkauf) |
10,000 |
$7.94 |
$79.4K |
| 2025-12-04 |
Leite John |
Chief Commercial Officer-clia |
Informierter Verkauf |
1,278 |
$47.51 |
$60.72K |
